Home
Conditions
T Cell Lymphoma

Clinical trial condition

T Cell Lymphoma

Explore clinical trials studying T Cell Lymphoma. Study availability and eligibility vary by location and protocol.

14 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

T Cell Lymphoma trial results

Recruiting

Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma

NCT05996185

Conditions: Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +19 more
Locations: Yale Cancer Center, Clinical Trials Office New Haven, Connecticut, United States

Icahn School of Medicine at Mount Sinai New York, United States

View Trial Details

Recruiting

Sequential CAR-T Cells Therapy for CD5/CD7 Positive T-cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Using CD5/CD7-Specific CAR-T Cells

NCT06420076

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +21 more
Locations: District One Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Azacitidine-CHOP for Patients With Nodal T-cell Lymphoma With T-follicular Helper Phenotype (ACANTUS)

NCT05230680

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: 81, Irwon-ro, Gangnam-gu, Seoul, Republic of Korea Seoul, South Korea

View Trial Details

Enrolling by Invitation

Long-term Follow-up of Patients Treated With Genetically Modified Autologous T Cells

NCT03628612

Conditions: ALL, Adult and Pediatric, Blood Protein Disorders, Cardiovascular Diseases, +20 more
Locations: University of Miami Miami, Florida, United States

Washington University in St. Louis St Louis, Missouri, United States

St David's South Austin Medical Center Austin, Texas, United States

Queen Elizabeth University Hospital Glasgow, United Kingdom

View Trial Details

Not Yet Recruiting

A Multi-center, Prospective, Registry Study to Analyze the Clinical Characteristics and Prognosis of Different Molecular Subtypes of Peripheral T-cell Lymphoma.

NCT07657572

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

CD7 CAR-T Combined With Autologous Hematopoietic Stem Cell Transplantation

NCT07117305

Conditions: CD7+ Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: The First Affiliated Hospital of Zhengzhou University, Department of Oncology Zhengzhou, Henan, China

View Trial Details

Completed

A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed/Refractory Hematologic Malignancies

NCT06492304

Conditions: Acute Myeloid Leukemia, B Cell Lymphoma, Hematologic Diseases, +15 more
Locations: Research Site 6 Phoenix, Arizona, United States

Research Site 5 Stanford, California, United States

Research Site 3 Boston, Massachusetts, United States

Research Site 4 New York, United States

View Trial Details

Completed

Understanding the Role of Large Extracellular Vesicles in Lymphomas and Lymphoproliferative Disorders: the "Off the Beaten Track" Liquid Biopsy

NCT06782854

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Diffuse Large B-cell Lymphoma, +30 more
Locations: IRCCS Azienda Ospedaliero-Universitaria di Bologna Bologna, Italy

View Trial Details

Completed

Phase I Clinical Trial of Autologous CD7-CAR T Cell Therapy for High-risk Acute T-cell Leukemia/lymphoma

NCT04840875

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: Beijing Boren Hospital Beijing, Beijing Municipality, China

View Trial Details

Completed

HuMax-CD4 in Non-Cutaneous T-Cell Lymphoma

NCT00877656

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Not specified

View Trial Details

T Cell Lymphoma

T Cell Lymphoma trial results

Related conditions